RAPP
Rapport Therapeutics
RAPP
RAPP
77 hedge funds and large institutions have $382M invested in Rapport Therapeutics in 2025 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 35 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
41% less capital invested
Capital invested by funds: $649M → $382M (-$267M)
50% less call options, than puts
Call options by funds: $10K | Put options by funds: $20K
Holders
77
Holding in Top 10
4
Calls
$10K
Puts
$20K
Top Buyers
| 1 | +$5.62M | |
| 2 | +$4.59M | |
| 3 | +$4.12M | |
| 4 |
UBS AM
Chicago,
Illinois
|
+$2.04M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$1.95M |
Top Sellers
| 1 | -$5.53M | |
| 2 | -$2.39M | |
| 3 | -$1.1M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$853K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$704K |
